Article
Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients.
The International journal of artificial organs - 1 Apr 2001
Dinçer D, Besisik F, Oğuz F, Sever M S, Kaymakoglu S, Cakaloglu Y, Demir K, Türkoglu S, Carin M, Okten A
Abstract excerpt
UNLABELLED: The prevalence of anti-HCV among patients on hemodialysis is consistently higher than in the general population, indicating that patients on hemodialysis programs are at risk of acquiring HCV infection. The response to interferon alpha 2b (IFN -alpha 2b) therapy in chronic C hepatitis depends on viral and host factors. We treated 22 chronic C hepatitis uremic patients with IFN -alpha 2b (3 MU three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
